Background Acute tryptophan depletion lowers brain serotonin synthesis and results in a transient, but striking, clinical relapse in recovered depressed patients.
There is extensive evidence that brain serotonin plays an important role in the pathophysiology of major depression and the psychotropic effects of antidepressant drug treatment (Smith & Cowen, 1997) . Tryptophan depletion is a dietary technique which involves the administration of an amino acid mixture which lacks tryptophan, the amino acid precursor of serotonin. Studies in both animals and humans have shown that a tryptophan-free amino acid mixture lowers plasma and brain tryptophan levels and decreases brain serotonin synthesis (Young et al, 1985; Nishizawa et al, 1997) . Previous studies have shown that tryptophan depletion can induce acute temporary depressive relapse in euthymic patients maintained on serotonergic antidepressants (Delgado et al, 1990 ) and in drug-free recovered depressed subjects (Smith et al, 1997) . The aim of the present study was to use tryptophan depletion in conjunction with positron-emission tomography (PET) to identify the brain regions associated with acute depressive relapse and its associated cognitive impairment.
METHOD

Subjects
Eight male subjects (mean age 39.1 years, range 27-64) took part in the study. Males were used in the study because of the difficulties in using neuroimaging techniques involving radioactivity in females of childbearing age. All subjects had a history of at least two episodes of DSM-III-R major depression (American Psychiatric Association, 1987) as assessed by the Structured Clinical Interview for DSM-111-R (SCID; Spitzer et al, 1990) . All subjects met criteria for full recovery from depression (Frank et al, 1991) and had been free of significant symptoms for at least six months. All subjects gave informed consent to the study and were explicitly informed that the procedure might cause a reappearance of some or all of their depressive symptoms. The study had received approval from the local research ethics committees and from the Administration of Radioactive S u b stances Advisory Committee (ARSAC, UK). Two of the subjects had been medicationfree for at least six months, the other six were maintained on antidepressant medication (three on selective serotonin reuptake inhibitors, one on amimptyline, one on a monoamine oxidase inhibitor (MAOI) and one on a combination of amitriptyline and MAOI). Two subjects on antidepressants were also taking lithium.
Experimental procedure
Subjects received two amino acid mixtures in a double-blind balanced-order design. One mixture was nutritionally balanced and contained tryptophan ('balanced mixture'), the other was identical except that it contained no tryptophan ('W-free mixture'). The composition of the mixtures was identical to those previously described (by Young et al, 1985) . The W -f x e mixture contained L-alanine 5.5 g, L-arginiie 4.9 g, L-cysteine 2.7 g, glycine 3.2 g, L-histidine 3.2 g, L-isoleucine 8 g, L-leucine 13.5 g, L-lysine monhydrochloride 11 g, L-methionine 3 g, L-phenylalanine 5.7 g, L-proline 12.2 g, L-serine 6.9 g, L-threonine 6.5 g, L-tyrosine 6.9 g and L-valine 8.9 g. The balanced drink contained the same amino acids plus 2.3 g L-tryptophan. Subjects followed the same protocol as a previous study of recovered depressed patients (Smith et al, 1997) . They were tested on two days separated by at least a week. Prior to each test day they followed a low protein diet to maximise the effects of subsequent tryptophan depletion. On each tea day, the amino acid mixture was given at 09.00 h. Following the mixture, subjects sat quietly in a testing room and were allowed to read neutral material. Subjects were given a low-tryptophan lunch at +3 hours and the PET scan started at +5 hours. Mood was rated objectively using the Hamilton Rating Scale for Depression (HAM-D) (Hamilton, 1960) , modified for use over a short period of time by removing five items (initial, middle and delayed insomnia, genital symptoms and loss of weight) which could not change during the course of the test (Smith et al, 1997) .
The HAM-D was used because previous studies of tryptophan depletion (Delgado et al, 1990) have shown that the main effects are on objective ratings of mood measured using this scale. The HAM-D test was completed by one of the investigators (K.S., who was blind to test status) at baseline, before and immediately after the PET scan. Partial and full reappearance of symptoms were judged by a modified HAM-D score of greater than 5 or greater than 11 respectively, as previously described (Smith et al, 1997) . For the purpose of analysis, values of HAM-D were assigned to each PET scan assuming a linear relationship between pre-and post-scan HAM-D ratings. Following the PET scan, subjects were takm home and monitored as clinically indicated.
Biochemical measures
Blood samples for measurement of total and free tryptophan were taken imrnediately before administration of the mixture and seven hours later. Plasma tryptophan levels were determined by high-performance liquid chromatography with amperometric detection.
Psychological tasks
During scanning, subjects performed either task 'a', a paced word repetition task, in which words were spoken by the experimenter every five seconds and immediately repeated by the subject, or task ' b ' , a paced orthographic verbal fluency task, in which a letter was repeated every five seconds by the experimenter and subjects generated a word beginning with that letter for each -- repetition. If the subject could not generate a word, he said "pass" and was given a new letter which was repeated in the same way.
A new letter was automatically introduced after ten repeats of a single letter. The tasks were alternated across the six scans in each session, with half the subjects having the
Image acquisition
Scans of the distribution of H,lSO were obtained using a SiemendCPS ECAT EXACT HR+ PET scanner operated in high sensitivity 3D mode. Subjects received a total of 350 Mbq of H2ISO over 20 seconds through a forearm cannula for each scan, and activity was measured during a 90second time window. Each subject had two sessions of six scans (i.e. a total of 12 scans). The PET images comprised 2 x 2 x 2 mm voxels with a 6.4 rnm transaxial and a 5.7 mm axial resolution (full width at half maximum). The data were analysed with statistical parametric mapping (SPM96, Wellcome Depamnent of Cognitive Neurology, London; httpJIwww.fil.ion.ucl.ac.uk/ spm) implemented on Matlab. Structural magnetic resonance images (MRIs) from each subject were co-registered to the PET data following realignment of the PET time series. All the scans were then transformed into a standard stereotactic space (Talairach & Tournoux, 1988; Friston et al, 19956) . The scans were smoothed using a Gaussian filter set at 12 mm full width at half maximum. The measurements were adjusted to a global mean of 50 mYdVmin.
Statistical analysis
A blocked (by subject) ANCOVA model was fitted to the data at each voxel, with a condition effect for each psychological task in each of the depleted or balanced sessions, and global cerebral blood flow (CBF) as a confounding covariate. Predetermined contrasts of the condition effects at each voxel were assessed using a t-statistic image for each contrast. Levels of total tryptophan and values from the HAM-D rating scale were used to generate covariates of interest for separate SPM96 analyses. Individual values for each scan were assigned by linear interpolation between pre-and post-scanning results. The general methods employed by SPM are described in detail elsewhere (Friston et al, 1995a,b) .
RESULTS
reappearance of depressive symptoms in six of the eight subjects according to the HAM-D criteria described above. One subject became partially symptomatic on the day he was given the balanced mixture (although his depression score was greater after tryptophan depletion). Reappearance of symptoms did not correlate with the presence or the type of medication on which the subjects were maintained. HAM-D scores on the tryptophan depletion and placebo days are shown in Fig. 1 .
The effect of increasing clinical depression on regional cerebral blood flow
We used a regression analysis to assess the effect of mood change on both the tryptophandepleted and balanced-mixture days, taking into account the effect of changing tryptophan levels. Increasing depression scores were significantly correlated (P < 0.001, uncorrected) with decreased activity in the orbitofrontal cortex, subgenual anterior cingulate, left caudate nucleus, left extrastriate cortex and superior parietal cortex bilaterally (Fig. 2 ). There were no increases in activity associated with increasing HAM-D score. The coordinates and associated Z-scores for mood-related decreases in regional cerebral blood flow are given in Table 1 .
The effect of psychological task on regional cerebral blood flow
The regional cerebral blood flow pattern Ratings of clinical depression produced by the psychological tasks (verbal In agreement with previous studies, tryptofluency contrasted with repetition) resulted phan depletion produced a full or partial in activations in the orbitofrontal cortex, Flg. I Changes in mood on the vrptophrn depletion (Fig. la) a d the balanced day (Fig. Ib) (when the c o n v d amino acid mixture was given). Mood was wucd using the modifkd Hamilton Rating Scale for D+prcukn at time 0 (just prior to the adminiswation of the amino acid mixture), at +5 hours (kfwc the positron-emission tomognphy (PET) san) and at +6 hours (after the PET-).
(2) denotes a line rtprrxnting tm, individuals. the effect of mood change on cognitivetask-associated activations. This interaction, between mood and cognitive task, was analysed using an orthogonalised HAM-D covariate with respect to changq ayptophan levels. We compared the difference in slope between the two e o n s of fluency and repetition on corrected HAM-D scores auoss both scanning sessions, tested at every voxel, to produce a statistical parametric map. No predicted areas of increased activation were revealed in the interaction of inueasing depression and verbal fluency. By contrast, a predicted effect was seen in the dorsal anterior cingulate, where there was a significant attenuation of activation (P<O.OOl, uncorrected) ( Fig. 3) under the fluency condition with increasing severity of depression.
PlPUMfirpfOphOn levels
A!kx ingestion of the TRP-free niixtUre the mean (s.e.) total plasma tryptophan level fell from 13.66 (0.6) to 2.3 (0.3), a reduction of 83%. On the balanced day, there was no siguificant change in total tryptophan levels (14.2 (1.1) to 15.3 (1.2)). Similar results were found for free tryptophan levels, with a fall of 87% after tryptophan depletion (data not shown).
DISCUSSION
Our data highlight the role of the medial prefrontal and orbital cortices in the manifestation of clinical depression. These data extend previous findings based on single time measummmts (Coodwh, 1996) , where it is difkicult to assess the relative importance of state and trait factors. The advantage of the tryptophan depletion paradigm is that it allows subjects to be used as their own controls in a manner which enables changes in neural activity to be explicitly
A m
Coordinates (x. y. z ) Z-rmre linked to relapse of depressad mood. On this basis, we found that incrrasing severity of Supwiorfmnal--!X(w) 3 &~( w M t e u r r , c c n m ) o f t h c o n t w j a d~w N c h r h o m m o d u h t k n d i u~~d c p r c r o a d d h r u b j c c t r p c r l a m a v a r al, 1997) . Our study, using subjects as their own controls, makes us confident that structural diffexmces between the two scanning sessions cannot provide an exclusive explanation for the observed functional differences in this latter region. Our results, involving on-line changes in clinical state, imply that the functional deficit in this area needs to be explained in terms of state as well as trait.
B d n circuits invoked in depression
Patients with anterior cingulate lesions display diminished motivation and a loss of interest (Devmky et al, 1995) key syrnp toms of major depression. The anterior cingulate has projections to the orbitofrontal cortex and limbic striatum (Kunishio & Haber, 1994) , and this circuit has been hypothesised to function abnormally in depression (Ebert & Ebmeier, 1996) . Consistent with this proposal, we observed deaeasiig activity associated with increasing severity of relapse in the orbitofrontal cortex and caudate nucleus. Animal and human studies indicate that the orbitofrontal cortex plays a central role in affective behaviour (Rolls et al, 1994) , while changff in activity in the caudate nucleus could underpin psychomotor changes which are prominent in depressive relapse during tryptophan depletion (Smith et 01, 1997) .
Cognitive deficit in depression
Our data also provide information on the brain regions involved in the impairment in cognitive performance seen in depression. Use of an appropriate cognitive task allows a degree of control over subjects' mental state during scanning. More critically, the use of a cognitive task enabled us to address the consequences of acute relapse into depression on the brain regions involved in an aspea of cognitive performance.
Our findings showed that increasing depression attenuated the responsiveness of the dorsal anterior cingulate to a verbal fluency task. Interestingly, a similar finding has been reported in healthy subjects during verbal fluency activation in a state of induced low mood (Baker et al, 1997) . The paced nature of our tasks ensured that differential task performance cannot explain our findings, although this procedure prevented an assessment of on-line performance data. However, it should be noted that clinical depression is associated with impaired performance on verbal fluency tasks (Trichard et al, 1995) .
Decreased activity of the dorsal anterior cingulate has been reported in previous studies of depressed patients (Ebert & Ebmeier, 1996) , while 'nonnalisation' of activity in this region accompanies recovery from depression (Goodwin, 1996) . Taken together, the suggest that decreased neural activity in the dorsal anterior cingulate cortex may underpin some of the reversible cognitive deficits associated with depressive illness.
Serotonin function md detpmdon
Serotonin pathways heavily innervate cortical and subcortical brain regions, including those identified in our study as being linked to increasing depression scores (Cudennec et al, 1993) . How changes in serotonin function exert their behavioural effects has hitherto been an unanswered question. We suggest that decreasing serotonin function exerts its effects on mood by specifically impairing neural activity in the caudate nucleus, ventral anterior cingulate and orbitofrontal cortex regions which underpin the expression of clinical depressive symp toms. Furthermore, impaired serotonin neurotransmission in the dorsal anterior cingulate cortex may be involved in the expression of the interaction h e e n pathological mood states and cognition.
